Replies to post #27847 on Intellipharmaceutics International Inc. (IPCI)

[cdnrx]

Wow. It seems FDA is looking at these products very carefully with the new FDA head......I believe Endo's opioid product was pulled as well, as it wasn't proved to be abuse resistant.

[cdnrx]

also, COLL up another 7% on EGLT's misfortune....recall, COLL also bounced when Endo's Opana was pulled.

[wimuskyfisherman]

Lex- This is not the first time that the FDA has made issue with food effect... Remember ELTP got a CRL a while back based on food effect. EVERYONE PLEASE DON'T FORGET THAT IPCI HAS ALREADY CLAIMED REXISTA HAS NO FOOD EFFECT.

No food effect could be a major milestone for Rexista at adcom... Stay tuned everyone!